|
Market Closed -
Toronto S.E.
23:24:12 23/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 32.45 CAD | -1.96% |
|
+0.09% | +30.64% |
| 10-23 | Amgen's Growth Drivers, Pipeline Could Support Longer-Term Outlook, Oppenheimer Says | MT |
| 10-23 | Oppenheimer Adjusts Amgen Price Target to $480 From $450, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,165B | |||||
| 645B | |||||
| 504B | |||||
| 380B | |||||
| 363B |
- Stock Market
- Stocks
- AMGN Stock
- AMGN Stock
- Charts Amgen Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
